Texas sues Sanofi for allegedly ’bribing’ providers to boost drug prescriptions
#Texas lawsuit#Sanofi#healthcare providers#prescription drugs#bribery allegations#Attorney General Ken Paxton#pharmaceutical litigation#Texas Health Care Program Fraud Prevention Act
📌 Key Takeaways
Texas sues Sanofi for allegedly bribing healthcare providers to prescribe medications
Sanofi denies allegations, stating programs comply with laws and support patients
Attorney General seeks over $1 million in damages and injunction
This is part of a pattern of similar lawsuits against pharmaceutical companies in Texas
📖 Full Retelling
Texas Attorney General Ken Paxton on Thursday sued Sanofi for allegedly 'bribing' providers to prescribe its medications over alternatives. The attorney general's office issued a statement saying that the company created programs to offer services to healthcare providers, which it alleges amounted to bribes in violation of the Texas Health Care Program Fraud Prevention Act. 'These services are structured to comply with applicable federal and state laws and are intended to support patients, not to influence prescribing decisions,' Sanofi said in a statement. 'The state's intervention has no bearing on the merits of this case, and Sanofi is zealously defending this litigation,' Sanofi added. Attorney General Paxton is seeking monetary relief of over a million dollars, including civil penalties, as well as an injunction to stop any further unlawful acts, the statement said. The Attorney General has previously sued Sanofi and Bristol-Myers Squibb for failing to disclose that their drug to prevent blood clots Plavix did not work effectively for certain patients. Last year, Texas also sued Eli Lilly for allegedly 'bribing' providers to prescribe its most profitable drugs, including the GLP-1 medications Mounjaro and Zepbound.
French multinational pharmaceutical and healthcare company
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the ...
No entity connections available yet for this article.
Deep Analysis
Why It Matters
The lawsuit highlights ongoing concerns about pharmaceutical companies influencing prescribing practices. It could set a precedent for state enforcement of anti-bribery laws in the healthcare sector.
Context & Background
Texas AG Ken Paxton has previously sued drugmakers for similar allegations
Sanofi is accused of offering services that may be viewed as bribes under Texas law
The case follows earlier suits against Eli Lilly and Bristol-Myers Squibb
What Happens Next
Sanofi has denied wrongdoing and is defending the case. The lawsuit will proceed through Texas courts, potentially leading to a trial and possible injunctions against the company.
Frequently Asked Questions
What is the Texas Health Care Program Fraud Prevention Act?
It prohibits fraudulent and deceptive practices in the provision of health care services and products.
What damages is Texas seeking?
The state seeks over a million dollars in monetary relief, including civil penalties.
Has Sanofi faced similar lawsuits before?
Yes, Sanofi has been sued by Texas for failure to disclose issues with its blood clot prevention drug Plavix.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry U.S. stocks end lower after hawkish Fed minutes; Walmart guidance falls short Gold largely flat as investors weigh geopolitical tensions, hawkish Fed minutes Berenberg sees more than 50% upside in this small-cap software stock Morgan Stanley identifies best gas stocks amid AI data center boom (South Africa Philippines Nigeria) Texas sues Sanofi for allegedly ’bribing’ providers to boost drug prescriptions By Reuters Stock Markets Published 02/19/2026, 07:25 PM Updated 02/19/2026, 07:31 PM Texas sues Sanofi for allegedly ’bribing’ providers to boost drug prescriptions 0 SNY 2.69% Feb 19 - Texas Attorney General Ken Paxton on Thursday sued Sanofi for allegedly "bribing" providers to prescribe its medications over alternatives. The attorney general’s office issued a statement saying that the company created programs to offer services to healthcare providers, which it alleges amounted to bribes in violation of the Texas Health Care Program Fraud Prevention Act. "These services are structured to comply with applicable federal and state laws and are intended to support patients, not to influence prescribing decisions," Sanofi said in a statement. "The state’s intervention has no bearing on the merits of this case, and Sanofi is zealously defending this litigation," Sanofi added. Attorney General Paxton is seeking monetary relief of over a million dollars, including civil penalties, as well as an injunction to stop any further unlawful acts, the statement said. The Attorney General has previously sued Sanofi and Bristol-Myers Squibb for failing to disclose that their drug to prevent blood clots Plavix did not work effectively for certain patients. Last year, Texas also sued Eli Lilly for allegedly "bribing" providers to prescribe its most profitable drugs, including the GLP-1 medications Mounjaro and Zepbound.
